20-17969893-CA-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_052865.4(MGME1):c.35delA(p.Gln12fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
MGME1
NM_052865.4 frameshift
NM_052865.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.07
Genes affected
MGME1 (HGNC:16205): (mitochondrial genome maintenance exonuclease 1) The protein encoded by this gene is a nuclear-encoded mitochondrial protein necessary for the maintenance of mitochondrial genome synthesis. The encoded protein is a RecB-type exonuclease and primarily cleaves single-stranded DNA. Defects in this gene have been associated with mitochondrial DNA depletion syndrome-11. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 4 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-17969893-CA-C is Pathogenic according to our data. Variant chr20-17969893-CA-C is described in ClinVar as [Pathogenic]. Clinvar id is 2041766.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MGME1 | NM_052865.4 | c.35delA | p.Gln12fs | frameshift_variant | 2/5 | ENST00000377710.10 | NP_443097.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MGME1 | ENST00000377710.10 | c.35delA | p.Gln12fs | frameshift_variant | 2/5 | 1 | NM_052865.4 | ENSP00000366939.5 | ||
MGME1 | ENST00000377709.1 | c.35delA | p.Gln12fs | frameshift_variant | 2/5 | 2 | ENSP00000366938.1 | |||
MGME1 | ENST00000377704.4 | c.35delA | p.Gln12fs | frameshift_variant | 2/3 | 3 | ENSP00000366933.4 | |||
OVOL2 | ENST00000486776.5 | n.492-12857delT | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2022 | This sequence change creates a premature translational stop signal (p.Gln12Argfs*30) in the MGME1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MGME1 are known to be pathogenic (PMID: 23313956). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MGME1-related conditions. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.